IFN-γ suspends the killing license of anti-tumor CTLs

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1407-1409
Number of pages	3
Journal	Journal of Clinical Investigation
Volume	110
Issue number	10
DOIs	https://doi.org/10.1172/JCI200217209
State	Published - Nov 2002

All Science Journal Classification (ASJC) codes

@article{91ad9116254e4ee2b60305d2704d767d,

title = "IFN-γ suspends the killing license of anti-tumor CTLs",

author = "Lukacher, {Aron E.}",

year = "2002",

month = nov,

doi = "10.1172/JCI200217209",

language = "English (US)",

volume = "110",

pages = "1407--1409",

journal = "Journal of Clinical Investigation",

issn = "0021-9738",

publisher = "American Society for Clinical Investigation",

number = "10",

}

TY - JOUR

T1 - IFN-γ suspends the killing license of anti-tumor CTLs

AU - Lukacher, Aron E.

PY - 2002/11

Y1 - 2002/11

UR - http://www.scopus.com/inward/record.url?scp=0036856108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036856108&partnerID=8YFLogxK

U2 - 10.1172/JCI200217209

DO - 10.1172/JCI200217209

M3 - Comment/debate

C2 - 12438437

AN - SCOPUS:0036856108

SN - 0021-9738

VL - 110

SP - 1407

EP - 1409

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

IS - 10

ER -